A third major coronavirus vaccine candidate has revealed promising results in late-stage trials.
COVID-19 cases are surging upward around the U.S., reaching 100,000 daily cases for the first time on Nov. 4 and 150,000 only eight days later.
The final efficacy analysis of its late-stage trial suggest Pfizer and BioNtech's vaccine is safe and effective at preventing COVID-19.
Japan was scheduled to host the Olympic Games in the summer of 2020, but the coronavirus pandemic forced officials to postpone the competition until 2021.
A deadly virus that causes fevers, abdominal pain, vomiting, bleeding gums, skin rash and pain behind the eyes can now jump from one person to another.
This comes a week after Pfizer announced similar results, providing hope that the world may soon have multiple vaccines that work effectively.
Planning to attend an event but unsure of the COVID-19 risk, and if you should go at all? There's an evidence-based interactive webtool that can help.